TC BIOPHARM HOLDINGS PLC-ADR (TCBP) Stock Analyst Ratings
USA - NASDAQ:TCBP - US87807D6085 - ADR
0.5 USD
-1.04 (-67.53%)
0.6701 USD
+0.17 (+34.02%)
ChartMill assigns a Buy % Consensus number of 83% to TCBP. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 48.96. This target is 9692% above the current price.
TCBP was analyzed by 7 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about TCBP.
In the previous month the buy percentage consensus was at a similar level.
TCBP was analyzed by 7 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-12-06 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-04-27 | HC Wainwright & Co. | Maintains | Buy |
| 2023-01-26 | HC Wainwright & Co. | Initiate | Buy |
TC BIOPHARM HOLDINGS PLC-ADR / TCBP FAQ
What is the price target for TCBP stock?
7 analysts have analysed TCBP and the average price target is 48.96 USD. This implies a price increase of 9692% is expected in the next year compared to the current price of 0.5.
How do analysts rate TC BIOPHARM HOLDINGS PLC-ADR (TCBP)?
The consensus rating for TC BIOPHARM HOLDINGS PLC-ADR (TCBP) is 82.8571 / 100 . This indicates that analysts generally have a positive outlook on the stock.
Can you provide the analyst count for TC BIOPHARM HOLDINGS PLC-ADR stock?
The number of analysts covering TC BIOPHARM HOLDINGS PLC-ADR (TCBP) is 7.